Dedicated Phase I — Phoenix, Arizona

Dedicated Phase I is a clinical research site located in Phoenix, Arizona, United States 85013.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Dedicated Phase I has participated in 3 clinical trials.

Therapeutic areas: Chronic Obstructive Pulmonary Disease, Mild Alzheimer's Disease, Diabetic Foot Ulcers.

Sponsors: MediciNova, Link Medicine Corporation, Phage Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dedicated Phase I?

Dedicated Phase I has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dedicated Phase I conducted?

Dedicated Phase I has 3 clinical trials on record. Their work covers Chronic Obstructive Pulmonary Disease, Mild Alzheimer's Disease, Diabetic Foot Ulcers.

Is Dedicated Phase I accredited by Crixeo Health?

Dedicated Phase I has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dedicated Phase I?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.